Skip to main content

Find Clinical Trials

Clinical trial condition

PTCL

Explore clinical trials studying PTCL. Study availability and eligibility vary by location and protocol.

13 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

PTCL trial results

Active, not recruiting

Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma

NCT06492629

Conditions: PTCL
Locations: Department of Medical Oncology Beijing, Beijing Municipality, China

View Trial Details

Completed

Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort

NCT03900442

Conditions: Advanced Cancer, PTCL
Locations: Epworth Healthcare Melbourne, Victoria, Australia

View Trial Details

Completed

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms

NCT03493451

Conditions: ALK-Positive Anaplastic Large Cell Lymphoma, ALK-negative Anaplastic Large Cell Lymphoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +36 more
Locations: British Columbia Cancer Agency the Vancouver Centre Vancouver, British Columbia, Canada

Peking University Third Hospital Beijing, Beijing Municipality, China

Beijing Hospital Beijing, Beijing Municipality, China

Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View all 24 locations

View Trial Details